AEMD (Aethlon Medical) Total Assets: $6.33 Mil (As of Mar. 2026)


AEMD Aethlon Medical Inc AEMD
23 GF Score
Price $0.74
! 1 Warning Sign
View Full Analysis

What is Aethlon Medical Total Assets?

Aethlon Medical AEMD -6.07% 23 Total Assets is $6.33 Mil as of Mar. 2026. GuruFocus rates AEMD with a GF Score™ of 23/100. The stock has 1 warning sign investors should review.

Aethlon Medical's Total Assets for the quarter that ended in Mar. 2026 was $6.33 Mil.

During the past 12 months, Aethlon Medical's average Total Assets Growth Rate was -29.70% per year. During the past 3 years, the average Total Assets Growth Rate was -24.00% per year. During the past 5 years, the average Total Assets Growth Rate was 4.80% per year. During the past 10 years, the average Total Assets Growth Rate was 28.10% per year.

During the past 13 years, Aethlon Medical's highest 3-Year average Total Assets Growth Rate was 933.20%. The lowest was -39.70%. And the median was -6.90%.

Total Assets is connected with ROA %. Aethlon Medical's annualized ROA % for the quarter that ended in Mar. 2026 was -104.74%. Total Assets is also linked to Revenue through Asset Turnover. Aethlon Medical's Asset Turnover for the quarter that ended in Mar. 2026 was 0.00.

Aethlon Medical  (NAS:AEMD) Total Assets Explanation

Total Assets is connected with ROA %.

Aethlon Medical's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=-7.536/( (8.057+6.333)/ 2 )
=-7.536/7.195
=-104.74 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Aethlon Medical's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=0/( (8.057+6.333)/ 2 )
=0/7.195
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Aethlon Medical Total Assets Related Terms

Aethlon Medical Total Assets Historical Data

* Premium members only.

The historical data trend for Aethlon Medical's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aethlon Medical Total Assets Chart

Aethlon Medical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.42 17.51 8.25 7.36 6.33

Aethlon Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.36 5.31 7.32 8.06 6.33
AEMD
23GF Score
Aethlon Medical Inc AEMD
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aethlon Medical Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Aethlon Medical's Total Assets for the fiscal year that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (A: Mar. 2026 )+Total Liabilities (A: Mar. 2026 )
=4.886+1.447
=6.33

Aethlon Medical's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=4.886+1.447
=6.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $6.33 Mil mean?
Aethlon Medical (AEMD) has a Total Assets of $6.33 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Aethlon Medical and its competitors.
Is Aethlon Medical's Total Assets too high?
Aethlon Medical's current Total Assets is $6.33 Mil. Overall, Aethlon Medical has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Aethlon Medical's Total Assets compare to VYCO and RBOT?
Aethlon Medical's Total Assets of $6.33 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Devices & Instruments company?
A good Total Assets depends on the Medical Devices & Instruments industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Aethlon Medical and its competitors. Aethlon Medical's current Total Assets is $6.33 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aethlon Medical stock overvalued right now?
Aethlon Medical (AEMD) has a current Total Assets of $6.33 Mil. The current Total Assets is $6.33 Mil. Aethlon Medical's overall GF Score™ is 23/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Aethlon Medical (AEMD), the current Total Assets is $6.33 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aethlon Medical Business Description

Address 11555 Sorrento Valley Road, Suite 203, San Diego, CA, USA, 92121
Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.
23GF Score

Get the complete analysis for AEMD

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.74
Price